Low-level light therapy, also called photobiomodulation (PBM), has emerged as a promising approach to Alzheimer's treatment, ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

Dr Berg explained that some individuals might notice amyloid-beta plaquing on the retina, which can lead to difficulties in distinguishing shades of grey and other colours. Studies suggest that ...

Beta-amyloid peptide toxicity has also been implicated in the development of retinal ganglion cell apoptosis in glaucoma. Another arm of So’s brain research studies the anti-inflammatory effects ...

Neuroimaging studies performed when the man was 73 years old revealed that he had elevated levels of amyloid beta plaques in his cortex compared to other individuals with the PSEN1-E280A mutation.

The aggregation of these proteins, which are known as "amyloid-beta," give rise to a chain of events that ultimately harm neurons and lead to their loss. "Alzheimer's disease involves a complex ...